# The HOPE Trial and the SMART Study

> **NCT03022032** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 102 (actual)

## Conditions studied

- Gynecologic Cancer

## Interventions

- **DEVICE:** Fitbit Zip
- **OTHER:** HOPE App
- **OTHER:** Standard of Care
- **DEVICE:** Fitbit Charge 2
- **OTHER:** SMART Study Intervention

## Key facts

- **NCT ID:** NCT03022032
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-12
- **Primary completion:** 2020-09-02
- **Final completion:** 2020-09-02
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03022032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03022032, "The HOPE Trial and the SMART Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03022032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*